Gamco Investors INC. ET AL Boosts Stock Holdings in Option Care Health, Inc. $OPCH

Gamco Investors INC. ET AL lifted its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 210.3% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 269,758 shares of the company’s stock after purchasing an additional 182,828 shares during the period. Gamco Investors INC. ET AL owned about 0.17% of Option Care Health worth $7,488,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Teton Advisors LLC purchased a new position in Option Care Health during the third quarter valued at approximately $482,000. Dimensional Fund Advisors LP lifted its holdings in Option Care Health by 6.6% during the third quarter. Dimensional Fund Advisors LP now owns 3,796,396 shares of the company’s stock worth $105,384,000 after buying an additional 235,413 shares during the period. Victory Capital Management Inc. boosted its position in Option Care Health by 129.5% during the 3rd quarter. Victory Capital Management Inc. now owns 383,605 shares of the company’s stock valued at $10,649,000 after acquiring an additional 216,489 shares in the last quarter. Segall Bryant & Hamill LLC boosted its position in Option Care Health by 2.3% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 346,813 shares of the company’s stock valued at $9,628,000 after acquiring an additional 7,853 shares in the last quarter. Finally, 111 Capital purchased a new position in shares of Option Care Health in the 3rd quarter valued at $281,000. 98.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

OPCH has been the subject of several recent research reports. Wall Street Zen lowered Option Care Health from a “buy” rating to a “hold” rating in a research report on Saturday, February 28th. Citizens Jmp reiterated a “market outperform” rating and issued a $38.00 target price (up from $36.00) on shares of Option Care Health in a research note on Tuesday, January 13th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Option Care Health from $31.00 to $36.00 and gave the stock a “buy” rating in a report on Tuesday, December 9th. Bank of America increased their price target on shares of Option Care Health from $32.00 to $35.00 and gave the company a “buy” rating in a research report on Tuesday, December 9th. Finally, Barrington Research raised their price target on shares of Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a report on Friday, January 16th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, Option Care Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $37.27.

Option Care Health Stock Performance

OPCH opened at $29.84 on Monday. The company has a market cap of $4.67 billion, a P/E ratio of 23.31, a price-to-earnings-growth ratio of 1.67 and a beta of 0.85. The company has a quick ratio of 0.96, a current ratio of 1.53 and a debt-to-equity ratio of 0.87. The firm’s 50-day moving average price is $33.83 and its 200-day moving average price is $30.69. Option Care Health, Inc. has a 52-week low of $24.24 and a 52-week high of $36.80.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Tuesday, February 24th. The company reported $0.46 EPS for the quarter, hitting analysts’ consensus estimates of $0.46. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The company had revenue of $1.47 billion during the quarter, compared to analysts’ expectations of $1.46 billion. During the same period last year, the business earned $0.44 EPS. Option Care Health’s revenue for the quarter was up 8.8% on a year-over-year basis. As a group, equities analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.